Monday March 26, 3:00 pm Eastern Time
Press Release
SOURCE: InterMune
InterMune Announces Webcast of Presentation at Banc of America Securities Healthcare Conference
BURLINGAME, Calif., March 26 /PRNewswire/ -- InterMune (Nasdaq: ITMN - news) announced that its presentation at the Banc of America Securities Healthcare Conference will be webcast live and may be accessed at by visiting our website at intermune.com and clicking on the ``Investor Relations'' icon.
W. Scott Harkonen, M.D., President and CEO of InterMune, will be speaking at the Four Seasons Hotel in Las Vegas, Nevada on Tuesday, March 27, 2001 at 7:30 a.m. (Pacific).
InterMune is a biotechnology company dedicated to the development and commercialization of innovative products for the treatment of serious pulmonary and infectious diseases and cancer. InterMune currently markets ACTIMMUNE® (Interferon gamma-1b) Injection in the United States for the treatment of chronic granulomatous disease (CGD) and severe, malignant osteopetrosis and is in Phase III clinical trials for the treatment of idiopathic pulmonary fibrosis (IPF) and multidrug-resistant tuberculosis (MDR TB). The company also markets Amphotec®, an FDA-approved lipid-complexed form of amphotericin B for the treatment of invasive aspergillosis, a life-threatening fungal infection. For more information about InterMune and ACTIMMUNE®, please visit InterMune's web sites at www.intermune.com and www.actimmune.com, or send e-mail to ir@intermune.com.
SOURCE: InterMune |
